<DOC>
	<DOCNO>NCT02418494</DOCNO>
	<brief_summary>This research trial study health-related symptom questionnaire measure quality life human immunodeficiency virus ( HIV ) -infected participant treat monitor anal lesion . Collecting information symptom patient diagnose anal lesion may help reduce risk anal cancer .</brief_summary>
	<brief_title>Health-Related Symptom Questionnaires Measuring Quality Life HIV-Infected Participants Treated Monitored Anal Lesions</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To develop Anal Cancer/HSIL Outcomes Research Study ( ANCHOR ) high-grade squamous intraepithelial lesion ( HSIL ) health-related quality life ( HRQoL ) Index ( HQI ) use state-of-the-art measure development methodology capture important HRQoL symptom concern person diagnose anal HSIL either treat untreated anal HSIL . OUTLINE : Participants complete ANCHOR HSIL HRQoL interview 45-60 minute , compare list symptom , concern , HRQOL impact relate HSIL diagnosis treatment . Some patient also complete cognitive interview 3 session .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Squamous Intraepithelial Lesions Cervix</mesh_term>
	<criteria>HIV1 infection Biopsyproven anal HSIL within prior six month Life expectancy great 5 year History anal cancer Inability understand write consent form</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>